Drug profile · INN
lenalidomide hydrate
REVLIMID PARTIAL CHANGE APPROVAL
lenalidomide hydrate (REVLIMID PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lenalidomide hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
lenalidomide hydrate (REVLIMID PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN lenalidomide hydrate
Brand REVLIMID PARTIAL CHANGE APPROVAL
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is lenalidomide hydrate?
lenalidomide hydrate (REVLIMID PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for lenalidomide hydrate?
REVLIMID PARTIAL CHANGE APPROVAL is a marketed brand name for lenalidomide hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.